欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Inhibition of PDE4B suppresses inflammation by increasing e

发布时间:2025-04-30

Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
 

Kensei Komatsu,Ji-Yun Lee,Masanori Miyata,Jae Hyang Lim,Hirofumi Jono,Tomoaki Koga,Haidong Xu,Chen Yan,Hirofumi Kai& Jian-Dong Li

The deubiquitinase CYLD acts as a key negative regulator to tightly control overactive inflammation. Most anti-inflammatory strategies have focused on directly targeting the positive regulator, which often results in significant side effects such as suppression of the host defence response. Here, we show that inhibition of phosphodiesterase 4B (PDE4B) markedly enhances upregulation of CYLD expression in response to bacteria, thereby suggesting that PDE4B acts as a negative regulator for CYLD. Interestingly, in Cyld-deficient mice, inhibition of PDE4B no longer suppresses inflammation. Moreover, PDE4B negatively regulates CYLD via specific activation of JNK2 but not JNK1. Importantly, ototopical post-inoculation administration of a PDE4 inhibitor suppresses inflammation in this animal model, thus demonstrating the therapeutic potential of targeting PDE4. These studies provide insights into how inflammation is tightly regulated via the inhibition of its negative regulator and may also lead to the development of new anti-inflammatory therapeutics that upregulate CYLD expression.

 

上一篇:科兴中维获中国生物制药5亿余美元投资
下一篇:西亚试剂:Summary: Induction of double-strand DNA breaks (DSBs) by en
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4